Table 6 Measles, mumps, rubella and VZV IgG serology results of 2018 attendees, analysed by their date of first clinic attendance–sub-analysis
From: Changing demographics and immunity to vaccine preventable diseases in people with HIV in Ireland
Variables | Positive | % | Negative | % | Total | P value |
|---|---|---|---|---|---|---|
Measles IgG | ||||||
First attendance 1987–2013 | 195 | 94 | 13 | 6 | 208 | |
First attendance 2014–2018 | 632 | 81 | 150 | 19 | 782 | < 0.001 |
Mumps IgG | ||||||
First attendance 1987–2013 | 188 | 87 | 28 | 13 | 216 | |
First attendance 2014–2018 | 639 | 82 | 143 | 18 | 782 | 0.066 |
Rubella IgG | ||||||
First attendance 1987–2013 | 196 | 91 | 19 | 215 | ||
First attendance 2014–2018 | 688 | 88 | 94 | 12 | 782 | 0.192 |
VZV IgG | ||||||
First attendance 1987–2013 | 693 | 94 | 42 | 735 | ||
First attendance 2014–2018 | 759 | 96 | 28 | 4 | 787 | 0.045 |